Affiris AG
Records under this name other than the patents Affiris AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,724,399 | Mimotopes of Alpha-Synuclein and Vaccines Thereof for the Treatment of Synucleinopathy Formerly held In force · High confidence | In force | High confidence | |
| US 9,533,030 | A Vaccine Capable of Inducing Formation of Antibodies Directed to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Vivo. Formerly held In force · High confidence | In force | High confidence | |
| US 10,933,123 | Peptide Vaccines Usable for Hypercholesterolemia Related Diseases. Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,980,657 | Peptide Vaccines for Hypercholesterolemia Related Diseases Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,478,454 | Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,646,565 | Treatment of Alzheimer's Disease (AD) with an Aluminum Salt Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,065,273 | Treatment and prevention of alzheimer's disease (AD) Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,147,873 | Treatment of Alzheimer's Disease (AD) with an Aluminum Salt Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,065,509 | Substances and methods for the use in prevention and/or treatment in huntingon's disease Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,406,197 | Substances and Methods for the Use in Prevention And/Or Treatment in Huntington's Disease Formerly held In force · High confidence | In force | High confidence |